Stocks and Investing Stocks and Investing
Tue, February 7, 2023
Mon, February 6, 2023

Tyler Van Buren Initiated (BBIO) at Buy on, Feb 6th, 2023


Published on 2024-10-28 01:24:17 - WOPRAI, Tyler Van Buren
  Print publication without navigation


Tyler Van Buren of Cowen & Co., Initiated "BridgeBio Pharma, Inc." (BBIO) at Buy on, Feb 6th, 2023.

Tyler has made no other calls on BBIO in the last 4 months.



There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Tyler's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Tyler


  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Decreased Target to $19 on, Monday, January 23rd, 2023
  • Anupam Rama of "JP Morgan" Maintained at Buy with Decreased Target to $19 on, Friday, November 18th, 2022

Contributing Sources